Invention Grant
- Patent Title: Human adenovirus serotype 5 vectors containing E1 and E2B deletions encoding the ebola virus glycoprotein
-
Application No.: US15542003Application Date: 2016-01-07
-
Publication No.: US10695417B2Publication Date: 2020-06-30
- Inventor: Frank R. Jones , Elizabeth Gabitzsch
- Applicant: Etubics Corporation
- Applicant Address: US WA Seattle
- Assignee: Etubics Corporation
- Current Assignee: Etubics Corporation
- Current Assignee Address: US WA Seattle
- Agency: Sheridan Ross P.C.
- International Application: PCT/US2016/012482 WO 20160107
- International Announcement: WO2016/112188 WO 20160714
- Main IPC: A61K39/12
- IPC: A61K39/12 ; A61K38/19 ; C12N15/861 ; A61K35/761
Abstract:
Methods for generating immune responses to Ebola virus antigens using adenovirus vectors that allow multiple vaccinations with the same adenovirus vector and vaccinations in individuals with preexisting immunity to adenovirus are provided.
Public/Granted literature
- US20170368161A1 METHODS AND COMPOSITIONS FOR EBOLA VIRUS VACCINATION Public/Granted day:2017-12-28
Information query
